Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH)
Grant: CA208765
National Institutes of Health (NIH)
Grant: DC016328
National Institutes of Health (NIH)
Grant: W81XWH-14-1-0593
National Institutes of Health (NIH)
Grant: 383428
NIDCD NIH HHS
Grant: R00 DC016328
NCI NIH HHS
Grant: R01 CA208765
NIDCD NIH HHS
Grant: K99 DC016328
National Institutes of Health
Grant: 5R01CA208765-03
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
National Institutes of Health
Grant: 4R00DC016328-03
Determining the roles of Ca2+-binding proteins in modulation of hair cell mechanotransduction
FWCI
1.32
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer
Additional file 2 of Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer
Additional file 1 of Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer
Additional file 1 of Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer